COGT MT Newswires 3 days ago Cogent Biosciences Says FDA Accepted Marketing Application for Bezuclastinib in Non-Advanced Systemic Mastocytosis
COGT GlobeNewswire 3 days ago Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
COGT Insider Monkey 4 days ago Is Cogent Biosciences (COGT) One of the Best Multibagger Stocks to Buy According to Billionaires? 📈 AI Sentiment Highly Positive 9/10
COGT MarketBeat 5 days ago Cogent Biosciences Touts Bezuclastinib Pivotal Wins, Eyes Up to Three FDA Filings and U.S. Launches 📈 AI Sentiment Highly Positive 9/10
COGT Motley Fool 6 days ago This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision
COGT Motley Fool 6 days ago Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug
COGT Motley Fool 6 days ago Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline
COGT Motley Fool 6 days ago Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned 📈 AI Sentiment Highly Positive 9/10